Items where Author is "Turner, MD"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 44.

Journal article

TURNER, M.D., 2017. The identification of TNFR5 as a therapeutic target in diabetes. Expert Opinion on Therapeutic Targets. ISSN 1472-8222

CRIPPS, M.J., HANNA, K., LAVILLA, C., SAYERS, S.R., CATON, P.W., SIMS, C., DE GIROLAMO, L., SALE, C. and TURNER, M.D., 2017. Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake. Scientific Reports, 7 (1), p. 13313. ISSN 2045-2322

BAGNATI, M., OGUNKOLADE, B.W., MARSHALL, C., TUCCI, C., HANNA, K., JONES, T.A., BUGLIANI, M., NEDJAI, B., CATON, P.W., KIESWICH, J., YAQOOB, M.M., BALL, G.R., MARCHETTI, P., HITMAN, G.A. and TURNER, M.D., 2016. Glucolipotoxicity initiates pancreatic β-cell death through 1 tumour necrosis factor receptor 5 (TNFR5 / CD40) mediated 2 STAT1 and NF-κB activation. Cell Death and Disease, 7, e2329. ISSN 2041-4889

SOMANATH, S., PARTRIDGE, C.J., MARSHALL, C., ROWE, T. and TURNER, M.D., 2016. Snapin mediates insulin secretory granule docking, but not trans-SNARE complex formation. Biochemical and Biophysical Research Communications, 473 (2), pp. 403-407. ISSN 0006-291X

TURNER, M.D., NEDJAI, B., HURST, T. and PENNINGTON, D.J., 2014. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1843 (11), pp. 2563-2582. ISSN 0167-4889

TURNER, M.D., CHAUDHRY, A. and NEDJAI, B., 2012. TNFR1 trafficking dysfunction opens the TRAPS door to proinflammatory cytokine secretion. Bioscience Reports, 32, pp. 105-112.

DOMINGUEZ, V., RAIMONDI, C., SOMANATH, S., BUGLIANI, M., LODER, M.K., EDLING, C.E., DIVECHA, N., DA SILVA-XAVIER, G., MARSELLI, L., PERSAUD, S.J., TURNER, M.D., RUTTER, G.A., MARCHETTI, P., FALASCA, M. and MAFFUCCI, T., 2011. Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells. Journal of Biological Chemistry, 286, pp. 4216-4225.

TURNER, M.D. and CHERNAJOVSKY, Y., 2011. Comment on: Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology, pp. 1525-1526.

NEDJAI, B., HITMAN, G.A., CHURCH, L.D., MINDEN, K., WHITEFORD, M.L., MCKEE, S., STJERNBERG, S., PETTERSSON, T., RANKI, A., HAWKINS, P., ARKWRIGHT, P.D., MCDERMOTT, M.F. and TURNER, M.D., 2011. Differential cytokine secretion resulting from p65 and c-Rel NF-kappaB subunit signaling in peripheral blood mononuclear cells of TNFR-associated periodic fever syndrome patients. Cell Immunology, 268, pp. 55-59.

NEDJAI, B., QUILLINAN, N., COUGHLAN, R.J., CHURCH, L., MCDERMOTT, M.F., HITMAN, G.A. and TURNER, M.D., 2011. Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A. Advances in Experimental Medicine and Biology, 691, pp. 409-419.

PERSAUD, S.J., ARDEN, C., BERGSTEN, P., BONE, A.J., BROWN, J., DUNMORE, S., HARRISON, M., HAUGE-EVANS, A., KELLY, C., KING, A., MAFFUCCI, T., MARRIOTT, C.E., MCCLENAGHAN, N., MORGAN, N.G., REERS, C., RUSSELL, M., TURNER, M.D., WILLOUGHBY, E., YOUNIS, M.Y.G., ZHI, Z. and JONES, P.M., 2010. Pseudoislets as primary islet replacements for research. Islets, 2, pp. 236-239.

SOMANATH, S., BARG, S., MARSHALL, C., SILWOOD, C.J. and TURNER, M.D., 2009. High extracellular glucose inhibits exocytosis by disruption of syntaxin 1A-containing lipid rafts. Biochemical and Biophysical Research Communications, 389, pp. 241-246.

NEDJAI, B., HITMAN, G.A., QUILLINAN, N., COUGHLAN, R.J., CHURCH, L.D., MCDERMOTT, M.F. and TURNER, M.D., 2009. Proinflammatory action of the antiinflammatory drug infliximab in TNF-receptor associated periodic syndrome. Arthritis & Rheumatism, 60, pp. 619-625.

NEJADI, B., HITMAN, G.A., YOUSAF, N., CHERNAJOVSKY, Y., STJERNBERG, S., PETTERSSON, T., RANKI, A., HAWKINS, P., ARKWRIGHT, P.D., MCDERMOTT, M.F. and TURNER, M.D., 2008. Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome. Arthritis & Rheumatism, 58, pp. 273-283.

TURNER, M.D., HITMAN, G.A., NEDJAI, B. and MCDERMOTT, M., 2008. Cell surface expression of TNFR1 in tumor necrosis factor receptor associated periodic syndrome: reply. Arthritis & Rheumatism, 58, pp. 2214-2215.

CHURCHMAN, S.M., CHURCH, L.D., SAVIC, S., COULTHARD, L.R., HAYWARD, B., NEDJAI, B., TURNER, M.D., MATHEWS, R.J., BAGULEY, E., HITMAN, G.A., GOOI, H.C., WOOD, P.M.D., EMERY, P. and MCDERMOTT, M.F., 2008. A novel TNFRSF1A splice mutation associated with increased NF-kappaB transcription factor activation in patients with TNF-receptor associated periodic syndrome (TRAPS). Annals of the Rheumatic Diseases, 67, pp. 1589-1595.

TURNER, M.D., FULCHER, F.K., SMITH, B.T., VELASQUEZ, C.R., AGANNA, E., PARTRIDGE, C.J., HITMAN, G.A., CLARK, A. and PATEL, Y.M., 2007. Calpain facilitates actin reorganization during glucose-stimulated insulin secretion. Biochemical and Biophysical Research Communications, 352, pp. 650-655.

TURNER, M.D., 2007. Coordinated control of both insulin secretion and insulin action through calpain-10 mediated regulation of exocytosis? Molecular Genetics and Metabolism, 91, pp. 305-307.

MARSHALL, C., HITMAN, G.A., CASSELL, P.G. and TURNER, M.D., 2007. Effect of glucolipotoxicity and rosiglitazone upon insulin secretion. Biochemical and Biophysical Research Communications, 356, pp. 756-762.

EVANS, J.S. and TURNER, M.D., 2007. Emerging functions of the calpain superfamily of cysteine proteases in neuroendocrine secretory pathways. Journal of Neurochemistry, 103, pp. 849-859.

AGANNA, E., BURRIN, J.M., HITMAN, G.A. and TURNER, M.D., 2006. Involvement of calpain and synaptotagmin Ca2+ sensors in hormone secretion from excitable endocrine cells. Journal of Endocrinology, 191.

LARA-LEMUS, R., LIU, M., TURNER, M.D., SCHERER, P., STENBECK, G., IYENGAR, P. and ARVAN, P., 2006. Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cell. Journal of Cell Science, 119, pp. 1833-1842.

TURNER, M.D., CASSELL, P.G. and HITMAN, G.A., 2005. Calpain-10: from genome search to function. Diabetes/Metabolism Research and Reviews, 21, pp. 505-514.

MARSHALL, C., HITMAN, G.A., PARTRIDGE, C.J., CLARK, A., MA, H., SHEARER, T.R. and TURNER, M.D., 2005. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Molecular Endocrinology, 19, pp. 213-224.

YOUSAF, N., GOULD, D.J., AGANNA, E., HAMMOND, L., MIRAKIAN, R.M., TURNER, M.D., HITMAN, G.A., MCDERMOTT, M. and CHERNAJOVSKY, Y., 2005. Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. Arthritis & Rheumatism, 52, pp. 2906-2916.

TURNER, M.D., 2004. Fatty acyl CoA-mediated inhibition of endoplasmic reticulum assembly. Biochimica et Biophysica Acta, 1693, pp. 1-4.

TURNER, M.D. and ARVAN, P., 2000. Protein traffic from the secretory pathway to the endosomal system in pancreatic beta-cells. Journal of Biological Chemistry, 275, pp. 14025-14030.

TURNER, M.D., PLUTNER, H. and BALCH, W.E., 1997. A Rab GTPase is required for homotypic assembly of the endoplasmic reticulum. Journal of Biological Chemistry, 272, pp. 13479-13483.

BLATCHFORD, D.E., HENDRY, K.A.K., TURNER, M.D., BURGOYNE, R.D. and WILDE, C.J., 1995. Vectorial secretion by constitutive and regulated pathways in mammary epithelial cells. Epithelial Cell Biology, 4, pp. 8-16.

TURNER, M.D., HANDEL, S.E., WILDE, C.J. and BURGOYNE, R.D., 1993. Differential effect of brefeldin A on phosphorylation of the caseins in lactating mouse mammary epithelial cells. Journal of Cell Science, 106, pp. 1221-1226.

RENNISON, M.E., KERR, M., ADDEY, C.P.V., HANDEL, S.E., TURNER, M.D., WILDE, C.J. and BURGOYNE, R.D., 1993. Inhibition of constitutive protein secretion from lactating mouse mammary epithelial cells by FIL (Feedback Inhibitor of Lactation) a secreted milk protein. Journal of Cell Science, 106, pp. 641-648.

TURNER, M.D., WILDE, C.J. and BURGOYNE, R.D., 1992. Exocytosis from permeabilized lactating mouse mammary epithelial cells: stimulation by Ca2+ and phorbol ester, but inhibition of regulated exocytosis by GTPgammaS. Biochemical Journal, 286, pp. 13-15.

TURNER, M.D., RENNISON, M.E., HANDEL, S.E., WILDE, C.J. and BURGOYNE, R.D., 1992. Proteins are secreted by both constitutive and regulated secretory pathways in lactating mouse mammary epithelial cells. Journal of Cell Biology, 117, pp. 269-278.

BURGOYNE, R.D., HANDEL, S.E., MORGAN, A., RENNISON, M.E., TURNER, M.D. and WILDE, C.J., 1991. Calcium, the cytoskeleton and calpactin (annexin II) in exocytotic secretion from adrenal chromaffin and mammary epithelial cells. Biochemical Society Transactions, 19, pp. 1085-1090.

Chapter in book

WILDE, C.J., ADDEY, C.V.P., BURGOYNE, R.D., CLARK, A.J., HANDEL, S.E., KERR, M.A., MCCLENAGHAN, M., RENNISON, M.E., SIMONS, J.P. and TURNER, M.D., 1994. Autocrine regulation of milk protein secretion. In: K. OKAMURA, ed., Animal cell technology: basic and applied aspects. Dordrecht: Kluwer Academic Publishers.

BURGOYNE, R.D., HANDEL, S.E., SUDLOW, A.W., TURNER, M.D., KUMAR, S., SIMONS, P., BLATCHFORD, D.R. and WILDE, C.J., 1994. The secretory pathway for milk protein secretion and its regulation. In: C.J. WILDE, M. PEAKER and C.H. KNIGHT, eds., Intercellular signalling in the mammary gland. New York: Plenum Press.

Conference contribution

TURNER, M.D., 2012. [Invited speaker]. In: OMICS International Conference on “Clinical & Cellular Immunology”, Chicago, 2012, Chicago.

TURNER, M.D., 2012. [Keynote speaker]. In: OMICS International Conference on “Clinical & Cellular Immunology”, Chicago, 2012, Chicago.

TURNER, M.D., 2011. [Invited speaker]. In: Advances in Inflammation and Translational Medicine, London, 2011, London.

TURNER, M.D., 2010. [Invited speaker]. In: FASEB Conference on “The Biology of Calpains in Health and Disease”, Scottsdale, USA, 2010, Scottsdale, USA.

TURNER, M.D., 2010. [Invited speaker]. In: UK Membrane Trafficking, London, 2010, London.

TURNER, M.D., 2009. [Invited speaker]. In: 12th International TNF Conference, Madrid, 2009, Madrid.

TURNER, M.D., 2005. [Invited speaker]. In: Third International Congress on “Familial Mediterranean Fever and Systemic Autoinflammatory Diseases”, Bethesda, USA, 2005, Bethesda, USA.

TURNER, M.D., 2004. [Invited speaker]. In: British Society for Cell Biology Annual Conference, Canterbury, 2004, Canterbury.

This list was generated on Sat Nov 18 00:21:01 2017 UTC.